Healey teases announcement on Mass. mifepristone stockpile after SCOTUS ruling


The destiny of a virtually $700,000 abortion tablet stockpile that has sat unused for greater than a 12 months is unclear after the U.S. Supreme Courtroom handed down a call Thursday that maintains public entry to the drug.

Hours after Supreme Courtroom justices unanimously dominated to protect entry to mifepristone — one among two drugs utilized in treatment abortion — Gov. Maura Healey mentioned she plans to announce subsequent steps for stockpile within the coming week and declined to offer extra particulars earlier than then.

“Well, we’re going to have more to say about that next week,” Healey mentioned exterior her State Home workplace. “But I want to be clear about today’s ruling. First off, it’s a no-brainer. It’s the obvious decision because from the beginning this has just been a political attack and the plaintiffs in that case had absolutely no standing, which is the legal term, to even be in the court.”

Healey directed her administration to buy 15,000 doses of mifepristone final April within the occasion of a scarcity after a Texas choose suspended federal approval of the drug.

Entry to the treatment remained obtainable after it shifted into the arms of the Supreme Courtroom and the stockpile sat dormant whereas the authorized problem performed out. Mifepristone has a shelf life of 5 years, in keeping with the Division of Public Health.

The Division of Public Health, which has possession of the drug, beforehand indicated it could take steps to distribute the stockpile based mostly on the ultimate courtroom ruling. However who will finally take management of the drugs has not been made clear.

A spokesperson for Healey declined to offer extra particulars on subsequent week’s announcement.

Supreme Courtroom justices mentioned opponents of mifepristone lacked the authorized standing to sue the U.S. Meals and Drug Administration over its approval of the drug and actions to make it simpler for folks to entry.

Justice Brett Kavanaugh wrote within the courtroom’s opinion that “federal courts are the wrong forum for addressing the plaintiffs’ concerns about FDA’s actions.”

Share post:


Latest Article's

More like this

New England Revolution outclassed 5-1 by Philadelphia Union

CHESTER, Pa. (AP) — Cavan Sullivan turned the youngest...